AAEP

New to The Street TV Announces the Interviews of Four Corporate Guest, Episode 541, Airing on Bloomberg TV as Sponsored Programming, Tonight, Thursday, January 4, 2024, 9:30 PM PT

Retrieved on: 
Thursday, January 4, 2024
Magos, Dark, Mastercard, Marketing, AAEP, Osteoarthritis, GOLD, Dasylirion, Worldwide Angel, Lloyd's of London, News, Data mining, Javits Center, Dog, VMX, Sotol, Interview, Web page, Airport, OTCQX, PROMO, Human, Host, Animal, Aircraft, Name, Privacy, Bloomberg Television, IP, Silver, FBI, Horse, Safety, History, Agave, Surf Air Mobility, Cat, ACL, FRA, Internet, OTCQB, Television, Veterinary medicine, Corporation, Theft, Learning, Gold, Air travel, Constitution, Crime, Veterinarian, MGM Resorts International, Cryptocurrency

New to The Street's 541st TV episode line-up features the following Five (5) Corporate interviews:

Key Points: 
  • New to The Street's 541st TV episode line-up features the following Five (5) Corporate interviews:
    1).
  • John informs viewers that the Company was at New York's Javits Convention Center for the 2023 United States Vet Show .
  • From the Nasdaq MarketSite Studio , New to Street features its newest TV business segment, "Money Makers," with TV Co-Hosts Colin Jordon and Jane King.
  • Viewers, please tune in next time for the newest cybersecurity topic on the "Sekur Privacy & Sekur Security– Weekly Hack" segment.

PetVivo Holdings, Inc. Achieves National Distribution of Spryng™ to More than 600 Veterinary Clinics in 49 States

Retrieved on: 
Monday, December 11, 2023
AAEP, Sale, Limp, TPLO, Osteoarthritis, Animal, Veterinarian, Therapy

This advance was demonstrated by the increase of veterinarian inquiries and podium speaker references related to Spryng at the American Association of Equine Practitioners (“AAEP”) conference over the past three years.

Key Points: 
  • This advance was demonstrated by the increase of veterinarian inquiries and podium speaker references related to Spryng at the American Association of Equine Practitioners (“AAEP”) conference over the past three years.
  • SPRYNG™ with OsteoCushion™ Technology, is an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles.
  • Such action promotes the restoration of proper joint mechanics, thereby aiding in the management of lameness and other joint-related afflictions, such as osteoarthritis.
  • “We are also seeing enthusiasm surrounding Spryng in the veterinary community with veterinarians sending us videos and images touting the benefits of Spryng,” said Mr. Lai.

New to The Street Announces Five Corporate Interviews, Episode 535, Airing on the FOX Business Network on Monday, December 4, 2023, at 10:30 PM PT

Retrieved on: 
Friday, December 1, 2023
McLaren, AAEP, Motivation, FDA, Health, Osteoarthritis, Javits Center, Dog, VMX, Risk management, Street, Interview, OTCQX, PROMO, Nursing, Human, Animal, Privacy, IP, McLaren Health Care Corporation, Horse, Safety, S&P, Cat, ACL, FRA, Internet, Insurance, Artificial intelligence, Veterinary medicine, Patient, CDI, Hospital, ETF, LOI, European Medicines Agency, Social media, Growth, Investment, Publication, Veterinarian, Politics, Organization, Cryptocurrency

As a clinical-stage biopharmaceutical business, ACXP is developing a new class of antibiotics for life-threatening bacterial infections.

Key Points: 
  • As a clinical-stage biopharmaceutical business, ACXP is developing a new class of antibiotics for life-threatening bacterial infections.
  • Based on positive data from Phase 2a and Phase 2b, management is now going forward with the FDA Phase 3.
  • The Company compared its top-line data with the currently used standard-of-care drugs in the marketplace, and Ibezapolstat has impressive positive results.
  • Phases 2a and 2b confirmed that the drug had success in 25 out of 26 patients, approximately 96% success with no reinfections.

New to The Street Announces its Five Business Guest Interviews, Episode 533, Airs on the FOX Business Network on Monday, November 27, 2023, at 10:30 PM PT

Retrieved on: 
Friday, November 24, 2023
Marketing, AAEP, Motivation, ICBC, Woman, Software, FDA, Osteoarthritis, Javits Center, VPN, VMX, Dog, Risk management, Big Tech, Communication, Gmail, Street, Interview, OTCQX, Nursing, Human, Commercial bank, Animal, Privacy, Horse, Safety, Capital, S&P, Sony Pictures, Cat, ACL, FRA, Internet, Veterinary medicine, Patient, Fox Business, Biopharmaceutical, FS, Education, Regulation D, CDI, Hospital, ETF, Industrial, European Medicines Agency, Social media, Growth, Investment, Publication, Veterinarian, Politics, Cryptocurrency

As a clinical-stage biopharmaceutical business, ACXP is developing a new class of antibiotics for life-threatening bacterial infections.

Key Points: 
  • As a clinical-stage biopharmaceutical business, ACXP is developing a new class of antibiotics for life-threatening bacterial infections.
  • Based on positive data from Phase 2a and Phase 2b, management is now going forward with the FDA Phase 3.
  • The Company compared its top-line data with the currently used standard-of-care drugs in the marketplace, and Ibezapolstat has impressive positive results.
  • Phases 2a and 2b confirmed that the drug had success in 25 out of 26 patients, approximately 96% success with no reinfections.

PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Diego, California

Retrieved on: 
Tuesday, November 21, 2023
AAEP, Limp, CEHM, Osteoarthritis, MBA, Joseph Manning, Animal, DVM, Horse, Veterinarian, Therapy, ACVS, San Diego Convention Center

PetVivo will exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology, a medical device injection of sterilized, extra-cellular matrix microparticles that are lubricious and spongy used in the treatment of lameness and other joint related afflictions, such as osteoarthritis.

Key Points: 
  • PetVivo will exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology, a medical device injection of sterilized, extra-cellular matrix microparticles that are lubricious and spongy used in the treatment of lameness and other joint related afflictions, such as osteoarthritis.
  • The AAEP is the largest veterinary equine conference that services the United States, and normally plays host to more than 5,000 participants including many of the top industry professionals.
  • If you would like to attend the presentations by Dr. Yarbrough and Dr. Manning the details are provided below.
  • Location: San Diego Convention Center in San Diego, California
    For more information about PetVivo Holdings, Inc. and its innovative product, Spryng, please contact [email protected] or visit https://petvivo.com/ and https://sprynghealth.com/ .

RENOVŌ® EQUINE ALLOGRAFT WILL SHOWCASE DURING THE 2023 AAEP ANNUAL CONVENTION

Retrieved on: 
Wednesday, November 15, 2023
Momentum, EAS, DRS, Amnion, Tissue, History, Intramuscular injection, DVM, AAEP, Horse, Joint, Medical imaging, Phoenix

ARGYLE, Texas, Nov. 15, 2023 /PRNewswire/ -- Equine Amnio Solutions, LLC (EAS), distributor of the RenoVō® advanced equine allograft, announced today that the product will feature prominently during the 69th Annual Convention of the American Association of Equine Practitioners (AAEP), San Diego, CA held November 29 to December 3, 2023.

Key Points: 
  • ARGYLE, Texas, Nov. 15, 2023 /PRNewswire/ -- Equine Amnio Solutions, LLC (EAS), distributor of the RenoVō® advanced equine allograft, announced today that the product will feature prominently during the 69th Annual Convention of the American Association of Equine Practitioners (AAEP), San Diego, CA held November 29 to December 3, 2023.
  • Danica Wolkowski, DVM of Momentum Equine Veterinary Specialists, Sherwood Park, Alberta, Canada, will present compelling RenoVō® clinical data on Friday, December 1 at 8:40 am in a presentation titled, "Effects of Intra-Articular Injection of an Acellular Equine Liquid Amniotic Allograft in Healthy Equine Joints."
  • Studies establish the product as a safe and highly effective alternative to other modalities in the clinical care of equine tissue injuries.
  • RenoVō® is manufactured by Equus Innovations (Phoenix, Arizona) and has been used in over 17,000 horses to date.

PetVivo Holdings, Inc. Announces Scheduled Presentations by PetVivo Veterinarians at the American Association of Equine Practitioners Convention in San Diego, California

Retrieved on: 
Thursday, November 2, 2023
Knowledge, Veterinarian, Forest Products Research Laboratory, Therapy, DVM, CEHM, ACVS, Limp, MBA, San Diego Convention Center, Osteoarthritis, Animal, AAEP, Medical device

Tom Yarbrough, DVM, ACVS, the Director of Product Research for PetVivo Holdings Inc., is providing a presentation entitled “Modern Wild West: Navigating the new classes of joint therapeutics”.

Key Points: 
  • Tom Yarbrough, DVM, ACVS, the Director of Product Research for PetVivo Holdings Inc., is providing a presentation entitled “Modern Wild West: Navigating the new classes of joint therapeutics”.
  • In addition, Joseph Manning, DVM, MBA, Senior Technical Veterinarian for PetVivo Holdings, inc., will be discussing the use of Spryng™ with OsteoCushion™ Technology in a presentation entitled “Advancements in Intra-Articular Therapies: Experiences with a novel collagen-elastin hydrogel microparticles (CEHM) biomaterial used intra-articularly for joint conditions in equines”.
  • If you would like to attend the presentations by Dr. Yarbrough and Dr. Manning the details are provided below.
  • PetVivo’s innovative product, SPRYNG™ with OsteoCushion™ Technology, is an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles; Spryng microparticles perform in the joint as wet, slippery micro-cushions used in the management of lameness and other joint related afflictions, such as osteoarthritis.

Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics

Retrieved on: 
Monday, August 7, 2023
PRT, Reno, Nevada, AAEP, Myhre, OTCQB, Tail, Melanoma, VCS, Medical imaging

Richland WA, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce that it certified three additional clinics to offer Isopet® Precision Radionuclide Therapy (PRT).

Key Points: 
  • Richland WA, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce that it certified three additional clinics to offer Isopet® Precision Radionuclide Therapy (PRT).
  • The Myhre Clinic will be focused on providing equine tumor therapy and just recently successfully treated the Myhre Clinic’s first Isopet® equine patient for a melanoma tumor located on the tail.
  • Hopkinton Animal Hospital and Indian Creek Veterinary Hospital are focused on small animal therapy.
  • Dr. Korenko stated, “We are excited about expanding the availability and awareness of the Isopet® Precision Radionuclide Therapy as a game changing treatment option for treating solid tumors.

ANTERIX ACTIVE ECOSYSTEM PROGRAM CELEBRATES SECOND ANNIVERSARY WITH OVER 100 MEMBERS

Retrieved on: 
Wednesday, May 24, 2023
Gulf Organization for Industrial Consulting, DER, EV, RAD, AAEP, Internet of things, GE, LTE, Ameren, ATEX, Growth, USAB, Internet service provider, Mobile phone, Renewable energy, Ecosystem

WOODLAND PARK, N.J., May 24, 2023 /PRNewswire/ -- Anterix (NASDAQ: ATEX) is spending the month of May celebrating the second anniversary of the Anterix Active Ecosystem Program ("AAEP"). Since its launch in May 2021, the ecosystem has continued to unite a rich and diverse group of innovators in a collective mission to support and accelerate secure 900 MHz private LTE solutions. 

Key Points: 
  • Ecosystem members enhance 900 MHz private broadband value by delivering the resiliency, security, and operational efficiency solutions needed for grid modernization
    WOODLAND PARK, N.J., May 24, 2023 /PRNewswire/ -- Anterix (NASDAQ: ATEX) is spending the month of May celebrating the second anniversary of the Anterix Active Ecosystem Program ("AAEP").
  • With 37 members at launch, the Anterix Active Ecosystem Program now has over 100 members focused on addressing the broad array of equipment, solutions, and services that utilities require to plan, build, operate, and capture value from their 900 MHz private wireless broadband network investments.
  • "Anterix is thrilled to reach this significant milestone, with the support of so many great innovators," said Steve Ryan, Vice President of Ecosystem and Partnerships Strategic Development at Anterix.
  • To learn more about the Anterix Active Ecosystem, click here .

SYNCHRONY STUDY ESTIMATES THE LIFETIME COST OF HORSE OWNERSHIP RANGES FROM $300,000 TO $924,000

Retrieved on: 
Wednesday, April 26, 2023
Lizard, Food, Life, AAEP, Horse, Breeding, Veterinarian, St. Louis Fed Financial Stress Index, MBA, Guinea, Total cost, Animal, Health, Rabbit, Cat, Synchrony Financial, APR, Bird, DVM, NYSE, Direct lending, Insurance, Online shopping, Synchrony

STAMFORD, Conn., April 26, 2023 /PRNewswire/ -- Horse owners nationwide vastly underestimate the lifetime cost of caring for a horse, which ranges from nearly $300,000 to $924,000, according to a new Synchrony (NYSE: SYF) study, "Equine Lifetime of Care." While 83 percent of horse owners say they are prepared for expenses, the actual costs may reach three or even four times higher than they expect. 

Key Points: 
  • The Equine Lifetime of Care report also indicates that horse owners typically start experiencing stress when an unexpected invoice reaches $1,500.
  • Equine is the third subject of Synchrony's Lifetime of Care research series, following Pet Lifetime of Care and Lifetime of Healthcare Costs .
  • The Synchrony Equine Lifetime of Care study included 1,231 U.S. horse owners and nearly 30 equine veterinarians.
  • Access the complete Equine Lifetime of Care study and flexible financing resources for horse owners and veterinarians.